fluoxetine has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 12 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bupropion responders were more likely to have trough blood levels above 30 ng/ml (chi 2 = 3." | 1.28 | Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome. ( Brickman, A; Goodnick, PJ; Klimas, NG; Sandoval, R, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (83.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pardini, M | 1 |
| Guida, S | 1 |
| Primavera, A | 1 |
| Krueger, F | 1 |
| Cocito, L | 1 |
| Gialloreti, LE | 1 |
| Singh, A | 1 |
| Garg, V | 1 |
| Gupta, S | 1 |
| Kulkarni, SK | 1 |
| Hickie, I | 1 |
| Wilson, A | 1 |
| Vercoulen, JH | 1 |
| Swanink, CM | 1 |
| Zitman, FG | 1 |
| Vreden, SG | 1 |
| Hoofs, MP | 1 |
| Fennis, JF | 1 |
| Galama, JM | 1 |
| van der Meer, JW | 1 |
| Bleijenberg, G | 1 |
| Cleare, AJ | 1 |
| Wessely, SC | 1 |
| Sharma, A | 1 |
| Kendall, MJ | 1 |
| Oyebode, F | 1 |
| Jones, D | 1 |
| Lynch, S | 2 |
| Seth, R | 1 |
| Wearden, AJ | 1 |
| Morriss, RK | 1 |
| Mullis, R | 1 |
| Strickland, PL | 1 |
| Pearson, DJ | 1 |
| Appleby, L | 1 |
| Campbell, IT | 1 |
| Morris, JA | 1 |
| Deale, A | 1 |
| Chalder, T | 1 |
| Wessely, S | 1 |
| Fraser, J | 1 |
| Everitt, BS | 1 |
| Goodnick, PJ | 1 |
| Sandoval, R | 1 |
| Brickman, A | 1 |
| Klimas, NG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Shanghai University of Traditional Chinese Medicine[NCT03496961] | 135 participants (Anticipated) | Interventional | 2018-12-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for fluoxetine and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study.
Topics: Amisulpride; Dopamine Antagonists; Fatigue Syndrome, Chronic; Female; Fluoxetine; Humans; Male; Pilo | 2011 |
Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Case-Control Studies; Depressive Disorder; Double-B | 1996 |
Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Double-Blind Method; Exe | 1998 |
9 other studies available for fluoxetine and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Role of antioxidants in chronic fatigue syndrome in mice.
Topics: Animals; Antioxidants; Brain; Carbazoles; Carvedilol; Catalase; Disease Models, Animal; Fatigue Synd | 2002 |
A catecholamine model of fatigue.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Benzamides; Brain; Catecholamines; Depressive D | 1994 |
Fluoxetine and chronic fatigue syndrome.
Topics: Antidepressive Agents, Second-Generation; Fatigue Syndrome, Chronic; Fluoxetine; Humans; Somatoform | 1996 |
Fluoxetine and chronic fatigue syndrome.
Topics: Antidepressive Agents, Second-Generation; Fatigue Syndrome, Chronic; Fluoxetine; Humans | 1996 |
Fluoxetine and chronic fatigue syndrome.
Topics: Antidepressive Agents, Second-Generation; Fatigue Syndrome, Chronic; Fluoxetine; Humans; Placebo Eff | 1996 |
Commentary on: randomised, double-blind, placebo-controlled trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Exercise Therapy; Fatigu | 1998 |
Fluoxetine and graded exercise in chronic fatigue syndrome.
Topics: Antidepressive Agents, Second-Generation; Combined Modality Therapy; Exercise Therapy; Fatigue Syndr | 1998 |
Analysis of drop-out data in treatment trials.
Topics: Data Interpretation, Statistical; Exercise Therapy; Fatigue Syndrome, Chronic; Fluoxetine; Humans; P | 1998 |
Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome.
Topics: Adult; Bupropion; Depressive Disorder; Fatigue Syndrome, Chronic; Female; Fluoxetine; Follow-Up Stud | 1992 |